Blackstone invests $2 bln in Alnylam Pharma
Blackstone Group Inc said on
Monday it invested $2 billion in Alnylam Pharmaceuticals Inc
through an equity-and-debt deal, giving the drugmaker a
financial boost to develop its experimental therapies.
Monday it invested $2 billion in Alnylam Pharmaceuticals Inc
through an equity-and-debt deal, giving the drugmaker a
financial boost to develop its experimental therapies.
Posted by Reuters
